Startseite > Publikationen

Publikationen

2212 Publikationen
Parhofer KG, Pittrow D, Birkenfeld AL, Fraass U, Hohenstein B, Siegert C, Klotsche J, Steinhagen-Thiessen E, Dexl S, Schettler VJJ, Laufs U.

Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies.

Clin Res Cardiol. 2026 Feb;115(2):288-303. doi: 10.1007/s00392-025-02719-z. Epub 2025 Aug 4. PMID: 40760109; PMCID: PMC12823742.
Treatment persistence, lipid lowering, and 3-year clinical outcomes in patients at very high cardiovascular risk on PCSK9 monoclonal antibodies.
Neue Erkenntnisse aus dem RABBIT-Register zum Krebsrisiko von Patient:innen mit rheumatoider Arthritis bei Therapie mit Januskinaseinhibitoren. [New results from the RABBIT register on the cancer risk of patients with rheumatoid arthritis treated with Janus kinase inhibitors].
Phithak E, Albach FN, Minopoulou I, Biesen R, Kleyer A, Wiebe E, Siegert E, Scholz V, Rehm M, Cheng Q, Sattler A, Bianco S, Fleischmann A, Hermann KG, Walter-Rittel T, Wagner M, Zernicke J, Casteleyn V, Nielsen M, Rose T, Busse A, Hütter-Krönke ML, Keller U, Schneider U, Kawelke L, Ruffer N, Stenzel W, Krönke G, Simon DN, Alexander A.

Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.

Ann Rheum Dis. 2026 Jan;85(1):212-215. doi: 10.1016/j.ard.2025.09.012. Epub 2025 Oct 23. PMID: 41130878.
Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome.
Jukic A, Hilbe R, Zundel L, Willeit P, Faserl K, Plattner C, Zollner A, Meyer M, Siegmund , Klepsch V, Marteau V, Vich VA, Schwärzler J, Vouk K, Kozsar A, Rieder D, Weichberger A, Sarg B, Grabherr F, Mayr L, Moser P, Nemati N, Scholl-Bürgi S, Karall D, Vogel GF, Welz L, Aldrian D, Koch R, Pfister A, Ran Q, Kaser A, Blumberg RS, Tancevski I, Sommer F, Bacher P, Schreiber S, Rosenstiel P, Aden K, Baier G, Bakiri L, Müller TM, Weiss G, TRR241 IBDome Consortium A, TRR241 IBDome Consortium A, TRR241 IBDome Consortium HD, Weersma RK, Trajanoski Z, Wagner EF, Tilg H, Adolph TE.

Fecal Detection of Calprotectin Subunits Links Inflammatory Bowel Disease Activity With Chronicity of Intestinal Inflammation.

Gastroenterology. 2026 Mar;170(3):523-538. doi: 10.1053/j.gastro.2025.08.040. Epub 2025 Nov 26. PMID: 41295942.
Fecal Detection of Calprotectin Subunits Links Inflammatory Bowel Disease Activity With Chronicity of Intestinal Inflammation.
1 218 219 220 221 222 246